August 2010 Briefing - Ophthalmology
Here are what the editors at HealthDay consider to be the most important developments in Ophthalmology for August 2010. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Study Links Genetic Variants to Fuchs's Corneal Dystrophy
WEDNESDAY, Aug. 25 (HealthDay News) -- Researchers have identified genetic variants that substantially increase the risk for Fuchs's corneal dystrophy (FCD), and their research has been published online Aug. 25 by the New England Journal of Medicine.
Retinopathy Common Among Adults With Diabetes in U.S.
TUESDAY, Aug. 10 (HealthDay News) -- Middle-aged and older Americans with diabetes have a high prevalence of diabetic retinopathy -- including vision-threatening retinopathy -- a finding that is especially notable in non-Hispanic blacks, according to research published in the Aug. 11 issue of the Journal of the American Medical Association.
Risk Factors for Glaucoma Visual Field Changes Identified
TUESDAY, Aug. 10 (HealthDay News) -- Visual field change in glaucoma occurs faster in patients with abnormal anticardiolipin antibody levels and higher age, but the change can be slowed with modest reductions in intraocular pressure (IOP), according to research published online Aug. 9 in the Archives of Ophthalmology.
Diverse Variables Affect Risk of Age-Related Cataracts
MONDAY, Aug. 9 (HealthDay News) -- The risk of cataracts can be increased by a combination of sun exposure and sun-sensitizing medications, by smoking, or even by socioeconomic factors, according to two studies in the August issue of the Archives of Ophthalmology.
Prayer Approach Positively Affects Hearing, Vision Impaired
FRIDAY, Aug. 6 (HealthDay News) -- Proximal intercessory prayer (PIP), a complementary and alternative medicine approach, may improve auditory and visual function in patients with impaired hearing and vision, according to a study published online Aug. 3 in the Southern Medical Journal.
Industry-Funded Clinical Trials Yield More Positive Outcomes
TUESDAY, Aug. 3 (HealthDay News) -- Drug clinical trials supported by industry are more likely to produce favorable results than trials supported by government or nonprofit/nonfederal organizations, and they are less likely to be published within two years of the study being completed, according to research published in the Aug. 3 issue of the Annals of Internal Medicine.
BMI Tied to Lower Risk of Glaucoma Subtype in Women
MONDAY, Aug. 2 (HealthDay News) -- In women, higher body mass index (BMI) appears to have an association with a reduced risk of primary open-angle glaucoma (POAG) with intraocular pressure (IOP) no more than 21 mm Hg, though there is no significant relationship between cumulatively averaged BMI and POAG overall, according to research published in the August issue of Ophthalmology.